tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Immunovant, Inc. (IMVT)
:IMVT
US Market
IMVT
Immunovant
RESEARCH TOOLSreports
Advertisement

Immunovant (IMVT) Stock News & Sentiment

Compare
918 Followers
Immunovant’s Earnings Call Highlights Clinical Success and Financial Strength
Premium
Company Announcements
Immunovant’s Earnings Call Highlights Clinical Success and Financial Strength
2d ago
IMVT
Immunovant’s Promising Clinical Progress and Market Potential Justifies Buy Rating
Premium
Ratings
Immunovant’s Promising Clinical Progress and Market Potential Justifies Buy Rating
2d ago
IMVT
Immunovant Reports Q2 2025 Financials and Clinical Progress
Premium
Company Announcements
Immunovant Reports Q2 2025 Financials and Clinical Progress
3d ago
IMVT
Is IMVT a Buy, Before Earnings?
Premium
Pre-Earnings
Is IMVT a Buy, Before Earnings?
5d ago
IMVT
3 Best Stocks to Buy Now, 9/4/2025, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 9/4/2025, According to Top Analysts
2M ago
IVA
IMVT
Immunovant’s Batoclimab Shows Promising Results in Phase 2 Study for Graves’ Disease, Earning Buy Rating
Premium
Ratings
Immunovant’s Batoclimab Shows Promising Results in Phase 2 Study for Graves’ Disease, Earning Buy Rating
2M ago
IMVT
Immunovant’s Promising Clinical Data and Strategic Advancements Drive Buy Rating
Premium
Ratings
Immunovant’s Promising Clinical Data and Strategic Advancements Drive Buy Rating
2M ago
IMVT
More IMVT News >

IMVT News on the Web

Immunovant's Q2 Loss Wider Than Expected, Pipeline in Focus
Zacks
Neutral
Why Immunovant, Inc.’s (IMVT) Stock Is Down 7.02%
AAII
Neutral
Why Immunovant, Inc.’s (IMVT) Stock Is Up 16.40%
AAII
Neutral
Why Immunovant, Inc.’s (IMVT) Stock Is Up 6.55%
AAII
Neutral
Why Immunovant, Inc.’s (IMVT) Stock Is Up 5.83%
AAII
Neutral
Why Immunovant, Inc.’s (IMVT) Stock Is Up 6.38%
AAII
Neutral
Why Immunovant, Inc.’s (IMVT) Stock Is Up 5.81%
AAII
Neutral
Why Immunovant, Inc.’s (IMVT) Stock Is Up 5.14%
AAII
Neutral

News Score - Last 7 Days

Neutral
IMVT
Sector Average
Media Buzz
This Week2 articles
Weekly Average1.5 articles
News Sentiment
This Week59%
Sector Average54%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is IMVT’s Media Buzz Sentiment?
2 articles about IMVT were published this week. In an average week, 1.5 articles are published.
    What is IMVT’s weekly average amount of articles?
    In an average week, 1.5 articles about IMVT are published.
      What is IMVT’s News Sentiment?
      59% of articles about IMVT were positive this week, compared to its sector average of 54%.
        Healthcare Stocks that are Trending in the News
        CVKDCadrenal Therapeutics, Inc.
        CNMDConmed
        RZLTRezolute
        NNVCNanoViricides
        TBPHTheravance Biopharma
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing